Novel Drug for Menopause Symptoms Passes Phase 3 Test ...Middle East

The novel NK3 receptor-inhibitor fezolinetant controlled vasomotor symptoms of menopause over 52 weeks in the phase 3 SKYLIGHT 2 trial. Medscape Medical News

Hence then, the article about novel drug for menopause symptoms passes phase 3 test was published today ( Thursday 16/06/2022 - 05:04 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Novel Drug for Menopause Symptoms Passes Phase 3 Test )

Also on site :

• This Iconic 1974 Dress Was Purchased Over 1 Million Times in Its First 2 Years—and It’s Still Popular Today
• Florida Retiree Loses $200K Thanks To Devastating Fake PayPal Scam
• ‘Verity’ Trailer: Anne Hathaway Lures Dakota Johnson Into “Darkness” In Colleen Hoover Adaptation From Amazon MGM Studios